Stock Snapshot from
Cytomedix IncAdd to My Watchlist
CMXI:USOTC BBIndustry: Medical-Biomedical/Gene
- 0.50Last
- 0.00 0.00%Today's Change
- 0.50Previous Close
- 52 Week Low - High
Earnings
| EPS: Year Actual ttm | -0.190 |
| EPS: Year Est. ttm | -- |
| EPS: Quarterly Actual | -0.05 |
| EPS: Quarterly Est. | -- |
| Price/Earnings ttm | -- |
| Relative Price/Earnings | -- |
| Earnings Growth Rate | -200.00 |
Company Description
| Cytomedix, Inc. is a global biotechnology company focused on developing and commercializing cellular therapies that serve unmet clinical needs. The Company markets the Autogel process and Procuren, autologous wound healing therapies with multiple growth factors designed to initiate the body's natural healing process. | |
| Revenue | $11 million |
| Net Income | $-20 million |
| Total Assets | $44 million |
| Employees | 35 |
| Web Site | www.cytomedix.com |
Latest Headlines
No news available.
Watchlist
Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.